BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19584238)

  • 1. Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis.
    McElroy MK; Kaushal S; Tran Cao HS; Moossa AR; Talamini MA; Hoffman RM; Bouvet M
    Mol Cancer Ther; 2009 Jul; 8(7):1779-86. PubMed ID: 19584238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1.
    Bocci G; Fioravanti A; Orlandi P; Di Desidero T; Natale G; Fanelli G; Viacava P; Naccarato AG; Francia G; Danesi R
    Neoplasia; 2012 Sep; 14(9):833-45. PubMed ID: 23019415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
    J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.
    Laklai H; Laval S; Dumartin L; Rochaix P; Hagedorn M; Bikfalvi A; Le Guellec S; Delisle MB; Schally AV; Susini C; Pyronnet S; Bousquet C
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17769-74. PubMed ID: 19805200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis.
    Schwarte-Waldhoff I; Volpert OV; Bouck NP; Sipos B; Hahn SA; Klein-Scory S; Lüttges J; Klöppel G; Graeven U; Eilert-Micus C; Hintelmann A; Schmiegel W
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9624-9. PubMed ID: 10944227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential.
    Sato N; Mizumoto K; Beppu K; Maehara N; Kusumoto M; Nabae T; Morisaki T; Katano M; Tanaka M
    Cancer Lett; 2000 Jul; 155(2):153-61. PubMed ID: 10822130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer.
    Sunamura M; Duda DG; Ghattas MH; Lozonschi L; Motoi F; Yamauchi J; Matsuno S; Shibahara S; Abraham NG
    Angiogenesis; 2003; 6(1):15-24. PubMed ID: 14517400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.
    Taeger J; Moser C; Hellerbrand C; Mycielska ME; Glockzin G; Schlitt HJ; Geissler EK; Stoeltzing O; Lang SA
    Mol Cancer Ther; 2011 Nov; 10(11):2157-67. PubMed ID: 21885862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.
    Seeliger H; Camaj P; Ischenko I; Kleespies A; De Toni EN; Thieme SE; Blum H; Assmann G; Jauch KW; Bruns CJ
    Mol Cancer Res; 2009 Feb; 7(2):189-98. PubMed ID: 19208748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.
    Firlej V; Mathieu JR; Gilbert C; Lemonnier L; Nakhlé J; Gallou-Kabani C; Guarmit B; Morin A; Prevarskaya N; Delongchamps NB; Cabon F
    Cancer Res; 2011 Dec; 71(24):7649-58. PubMed ID: 22037878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
    Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
    Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors.
    Olsson A; Björk A; Vallon-Christersson J; Isaacs JT; Leanderson T
    Mol Cancer; 2010 May; 9():107. PubMed ID: 20470445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
    Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
    Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
    Elaraj DM; Weinreich DM; Varghese S; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Alexander HR
    Clin Cancer Res; 2006 Feb; 12(4):1088-96. PubMed ID: 16489061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
    Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
    Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK8 regulates the angiogenesis of pancreatic cancer cells in part via the CDK8-β-catenin-KLF2 signal axis.
    Wei R; Kong L; Xiao Y; Yuan H; Song Y; Wang J; Yu H; Mao S; Xu W
    Exp Cell Res; 2018 Aug; 369(2):304-315. PubMed ID: 29856990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density.
    Kasper HU; Ebert M; Malfertheiner P; Roessner A; Kirkpatrick CJ; Wolf HK
    Virchows Arch; 2001 Feb; 438(2):116-20. PubMed ID: 11253112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.